SPRY | | ARS Pharmaceuticals, Inc. | Thompson Peter A. | Director | Aug 26, 2024 | Sale | $13.00 | 83,695 | 1,088,035 | 0 | Aug 28, 2024, 04:30 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Thompson Peter A. | Director | Aug 22, 2024 | Sale | $12.94 | 391,482 | 5,065,777 | 153,195 | Aug 23, 2024, 06:41 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Thompson Peter A. | Director | Aug 23, 2024 | Sale | $13.03 | 69,500 | 905,585 | 83,695 | Aug 23, 2024, 06:41 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Thompson Peter A. | Director | Aug 21, 2024 | Sale | $13.56 | 407,700 | 5,526,601 | 557,977 | Aug 23, 2024, 06:41 PM |
EWTX | | Edgewise Therapeutics, Inc. | Thompson Peter A. | Director | Jan 23, 2024 | Buy | $11.00 | 454,545 | 4,999,995 | 14,436,497 | Jan 25, 2024, 04:32 PM |
ALPN | | ALPINE IMMUNE SCIENCES, INC. | Thompson Peter A. | Director | Jan 11, 2024 | Option Exercise | $12.74 | 145,251 | 1,850,498 | 2,416,181 | Jan 16, 2024, 04:36 PM |
ALPN | | ALPINE IMMUNE SCIENCES, INC. | Thompson Peter A. | Director | Dec 27, 2023 | Sale | $19.96 | 181,498 | 3,622,700 | 3,493,485 | Dec 29, 2023, 04:20 PM |
ALPN | | ALPINE IMMUNE SCIENCES, INC. | Thompson Peter A. | Director | Dec 28, 2023 | Sale | $18.35 | 1,364,849 | 25,049,033 | 3,466,613 | Dec 29, 2023, 04:20 PM |
SPRY | | ARS Pharmaceuticals, Inc. | Thompson Peter A. | Director | Aug 29, 2023 | Buy | $6.20 | 500,000 | 3,100,000 | 8,019,187 | Aug 31, 2023, 05:18 PM |
EWTX | | Edgewise Therapeutics, Inc. | Thompson Peter A. | Director | Sep 16, 2022 | Buy | $10.32 | 484,496 | 4,999,999 | 13,981,952 | Sep 16, 2022, 04:34 PM |
EWTX | | Edgewise Therapeutics, Inc. | Thompson Peter A. | Director | May 18, 2022 | Buy | $7.21 | 138,000 | 994,980 | 13,497,456 | May 20, 2022, 04:32 PM |
JANX | | Janux Therapeutics, Inc. | Thompson Peter A. | Director | Dec 29, 2021 | Sale | $20.30 | 40,400 | 820,120 | 2,258,566 | Dec 30, 2021, 08:55 PM |
JANX | | Janux Therapeutics, Inc. | Thompson Peter A. | Director | Dec 21, 2021 | Sale | $19.00 | 119,400 | 2,268,600 | 2,295,266 | Dec 23, 2021, 04:08 PM |
JANX | | Janux Therapeutics, Inc. | Thompson Peter A. | Director | Dec 16, 2021 | Sale | $19.07 | 393,300 | 7,500,231 | 2,403,566 | Dec 17, 2021, 05:16 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Sep 20, 2021 | Sale | $6.09 | 1,109,644 | 6,757,732 | 6,943,654 | Sep 22, 2021, 05:24 PM |
ALPN | | ALPINE IMMUNE SCIENCES, INC. | Thompson Peter A. | Director | Sep 17, 2021 | Buy | $9.40 | 1,010,637 | 9,499,987 | 3,656,061 | Sep 21, 2021, 06:38 PM |
JANX | | Janux Therapeutics, Inc. | Thompson Peter A. | Director | Jun 15, 2021 | Buy | $17.00 | 705,853 | 11,999,501 | 2,760,366 | Jun 16, 2021, 06:20 PM |
EWTX | | Edgewise Therapeutics, Inc. | Thompson Peter A. | Director | Mar 30, 2021 | Buy | $16.00 | 359,375 | 5,750,000 | 13,359,456 | Mar 31, 2021, 07:11 PM |
DBTX | | Decibel Therapeutics, Inc. | Thompson Peter A. | Director | Feb 17, 2021 | Buy | $18.00 | 1,666,666 | 29,999,988 | 3,843,206 | Feb 19, 2021, 06:50 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Feb 17, 2021 | Buy | $3.50 | 1,285,714 | 4,499,999 | 8,053,298 | Feb 19, 2021, 04:47 PM |
ALPN | | ALPINE IMMUNE SCIENCES, INC. | Thompson Peter A. | Director | Dec 28, 2020 | Sale | $14.25 | 600,000 | 8,550,000 | 3,070,955 | Dec 30, 2020, 04:38 PM |
SBTX | | Silverback Therapeutics, Inc. | Thompson Peter A. | Director | Dec 08, 2020 | Buy | $21.00 | 952,377 | 19,999,917 | 952,377 | Dec 08, 2020, 08:43 PM |
SBTX | | Silverback Therapeutics, Inc. | Thompson Peter A. | Director | Dec 08, 2020 | Buy | $21.00 | 238,100 | 5,000,100 | 507,423 | Dec 08, 2020, 08:43 PM |
PMVP | | PMV Pharmaceuticals, Inc. | Thompson Peter A. | Director | Sep 25, 2020 | Buy | $18.00 | 950,000 | 17,100,000 | 475,000 | Sep 29, 2020, 04:38 PM |
THOR | | Synthorx, Inc. | Thompson Peter A. | Director | Jan 23, 2020 | Option Exercise | $68.00 | 5,316,355 | 361,512,140 | 0 | Jan 24, 2020, 06:44 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Aug 06, 2019 | Buy | $3.51 | 142,656 | 500,723 | 6,767,584 | Aug 08, 2019, 05:00 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 27, 2019 | Buy | $3.34 | 32,923 | 109,963 | 6,000,507 | Jul 01, 2019, 06:16 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 28, 2019 | Buy | $3.72 | 565,178 | 2,102,462 | 6,565,685 | Jul 01, 2019, 06:16 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jul 01, 2019 | Buy | $3.91 | 59,243 | 231,640 | 6,624,928 | Jul 01, 2019, 06:16 PM |
PRVL | | Prevail Therapeutics Inc. | Thompson Peter A. | Director | Jun 24, 2019 | Buy | $17.00 | 882,352 | 14,999,984 | 13,822,463 | Jun 26, 2019, 04:56 PM |
ALPN | | ALPINE IMMUNE SCIENCES, INC. | Thompson Peter A. | Director | Jan 18, 2019 | Buy | $5.37 | 372,439 | 1,999,997 | 3,670,955 | Jan 23, 2019, 06:01 PM |
THOR | | Synthorx, Inc. | Thompson Peter A. | Director | Dec 11, 2018 | Buy | $11.00 | 1,363,636 | 14,999,996 | 5,316,355 | Dec 13, 2018, 06:37 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | Jun 04, 2018 | Sale | $13.57 | 17,100 | 232,047 | 4,902,910 | Jun 06, 2018, 06:16 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | Jun 06, 2018 | Sale | $13.49 | 1,600 | 21,584 | 4,901,310 | Jun 06, 2018, 06:16 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | May 30, 2018 | Sale | $13.52 | 121,000 | 1,635,920 | 4,970,010 | Jun 01, 2018, 05:27 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | Jun 01, 2018 | Sale | $13.49 | 50,000 | 674,500 | 4,920,010 | Jun 01, 2018, 05:27 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | May 14, 2018 | Sale | $13.50 | 10,300 | 139,050 | 5,091,010 | May 16, 2018, 05:26 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | Mar 27, 2018 | Sale | $11.50 | 1,016,084 | 11,684,966 | 5,133,293 | Mar 29, 2018, 06:58 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | Mar 29, 2018 | Sale | $11.53 | 31,983 | 368,764 | 5,101,310 | Mar 29, 2018, 06:58 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Mar 12, 2018 | Buy | $8.50 | 588,235 | 4,999,998 | 5,967,584 | Mar 14, 2018, 02:05 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | Mar 27, 2017 | Buy | $4.20 | 1,190,476 | 4,999,999 | 6,149,377 | Mar 28, 2017, 06:54 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 23, 2016 | Buy | $12.92 | 100 | 1,292 | 5,378,449 | Jun 27, 2016, 06:51 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 24, 2016 | Buy | $12.99 | 900 | 11,691 | 5,379,349 | Jun 27, 2016, 06:51 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 21, 2016 | Buy | $12.87 | 26,083 | 335,688 | 5,378,349 | Jun 21, 2016, 07:00 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 17, 2016 | Buy | $12.48 | 12,300 | 153,504 | 5,352,266 | Jun 21, 2016, 07:00 PM |
RBM | | RESPONSE BIOMEDICAL CORP | Thompson Peter A. | Director | Jun 16, 2016 | Buy | $0.56 | 892,858 | 500,000 | 3,604,266 | Jun 20, 2016, 05:44 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 14, 2016 | Buy | $12.71 | 10,000 | 127,100 | 5,329,966 | Jun 16, 2016, 06:05 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 15, 2016 | Buy | $11.94 | 5,000 | 59,700 | 5,334,966 | Jun 16, 2016, 06:05 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 16, 2016 | Buy | $12.04 | 5,000 | 60,200 | 5,339,966 | Jun 16, 2016, 06:05 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 10, 2016 | Buy | $12.98 | 20,000 | 259,600 | 5,319,966 | Jun 13, 2016, 05:23 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Jun 09, 2016 | Buy | $12.95 | 30,000 | 388,500 | 5,299,966 | Jun 13, 2016, 05:23 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | May 20, 2016 | Buy | $10.04 | 2,400 | 24,096 | 28,043,404 | May 25, 2016, 06:45 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | May 23, 2016 | Buy | $10.40 | 1,191,600 | 12,392,640 | 29,235,004 | May 25, 2016, 06:45 PM |
ADAP | | Adaptimmune Therapeutics PLC | Thompson Peter A. | Director | May 24, 2016 | Buy | $10.48 | 518,400 | 5,432,832 | 29,753,404 | May 25, 2016, 06:45 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | May 20, 2016 | Buy | $13.09 | 4,716 | 61,732 | 5,269,966 | May 24, 2016, 04:48 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | May 18, 2016 | Buy | $11.55 | 4,200 | 48,510 | 5,262,650 | May 20, 2016, 04:27 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | May 19, 2016 | Buy | $12.13 | 2,600 | 31,525 | 5,265,250 | May 20, 2016, 04:27 PM |
CRVS | | Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director | Mar 29, 2016 | Buy | $15.00 | 550,000 | 8,250,000 | 5,258,450 | Mar 29, 2016, 12:00 PM |
DNAI | | ProNAi Therapeutics Inc | Thompson Peter A. | Director | Jul 21, 2015 | Option Exercise | $5.22 | 89,159 | 464,964 | 1,814,949 | Jul 21, 2015, 07:03 PM |
DNAI | | ProNAi Therapeutics Inc | Thompson Peter A. | Director | Jul 21, 2015 | Buy | $17.00 | 175,000 | 2,975,000 | 1,989,949 | Jul 21, 2015, 07:03 PM |